A young man presents with HBsAg positive anti HBcIgM positive, HBeAg negative and normal levels ofAST and ALT. He is asymptomatic. What is the next line of management.

Okay, let's tackle this question. The patient is HBsAg positive, which means he has hepatitis B. The anti-HBc IgM positive suggests an acute infection because IgM is typically present during the acute phase. HBeAg negative might indicate that the virus isn't actively replicating as much, but I need to think about the implications here.

AST and ALT are normal, so there's no evidence of liver inflammation currently. The patient is asymptomatic. So, in this case, the next step would be to monitor. Acute hepatitis B often resolves on its own, especially if the enzymes are normal and there are no symptoms. Wait, but what about the HBeAg status? HBeAg negative can sometimes mean a lower viral load or a different phase of the infection.

The options aren't given, but the correct answer is likely to be observation or follow-up. Maybe checking for anti-HBe or HBV DNA levels to determine the stage. Also, ensuring the patient is aware of the infection and avoiding alcohol or hepatotoxic drugs. Maybe vaccination for close contacts. The key here is that with normal liver enzymes and no symptoms, treatment isn't necessary right away. The main thing is to monitor for progression to chronic hepatitis B.

**Core Concept**
This question tests understanding of **hepatitis B serology and management**. The combination of HBsAg, anti-HBc IgM, and HBeAg status helps differentiate acute vs. chronic infection. Normal transaminases in acute HBV indicate a **non-inflamed carrier state** rather than active hepatitis.

**Why the Correct Answer is Right**
The patient has **acute hepatitis B infection** (HBsAg + anti-HBc IgM) but **no active inflammation** (normal AST/ALT). HBeAg negativity suggests **low viral replication** or a **non-replicative carrier phase**. Management here is **observation** with serologic follow-up to confirm resolution (anti-HBs development) or transition to chronic carrier state (>6 months HBsAg persistence). No antiviral therapy is needed due to lack of liver injury.

**Why Each Wrong Option is Incorrect**
**Option A:** Immediate antiviral therapy is incorrect—used only for chronic HBV with active inflammation.
**Option B:** Liver biopsy is unnecessary in asymptomatic patients with normal enzymes.
**Option C:** Vaccination is irrelevant; the patient is already infected with HBsAg positive.

**Clinical Pearl**
Remember the **"HBV serology cascade":**
1. Acute infection: HBsAg + anti-HBc IgM
2. Chronic infection: HBsAg + anti-HBc IgG
3. Recovery: Anti-HBs + anti-HBc IgG
Normal enzymes in acute phase = carrier state, not active hepatitis.

**Correct Answer: C. Observation with repeat serology in 3-6 months**

✓ Correct Answer: A. Wait and Watch